Healthcare & Biotech

Barnard, Vt. – September 13, 2026 -- MIB Agents began accepting letters of intent on September 9 for its 2027 OutSmarting Osteosarcoma research grant cycle, offering a combined $150,000 to fund translational studies on the pediatric bone cancer.

Two grants totaling $150,000 target established and emerging researchers

The 2027 cycle includes a $100,000 Hero Grant and a $50,000 Hope Young Investigator Grant. Since launching in 2017, the program has distributed more than $2.9 million across 37 investigators studying osteosarcoma, an aggressive primary bone cancer diagnosed in roughly 1,000 people annually in the United States, nearly half of them children, adolescents and young adults.

Austin, Texas – September 13, 2026 -- Findhelp has become the first specialty exchange to register with the Maryland Health Care Commission (MHCC), enabling social care referral and reporting support for the state's Rural Health Transformation Program (RHTP).

Findhelp registers as Maryland's first specialty exchange under MHCC oversight

The registration allows Findhelp to help RHTP grant awardees manage social risk screening, referrals, data exchange, and reporting requirements. Health care providers and community-based organizations (CBOs) gain specialized technical capabilities intended to reduce barriers in care coordination for rural patients.

New York – September 13, 2026 -- Albaron Partners, LP has completed the sale of Texas-based Prime Wellness LLC, doing business as Prime Psychiatry, to Beacon Behavioral Partners, ending a four-year buildout of the outpatient and interventional psychiatry provider.

Albaron built Prime Psychiatry into a regional platform since 2022

Albaron partnered with founder Dr. Efosa Airuehia in 2022 to scale Prime Psychiatry across the Dallas-Fort Worth and Austin metro areas. The practice treats children, adolescents, and adults, offering anxiety and depression treatment, medication management, TMS, and Spravato therapy.

Boston – September 13, 2026 -- Clearway Health has appointed Rishi Seth as chief operating officer, adding a 20-year healthcare operations veteran to its executive leadership team as the specialty pharmacy sector undergoes rapid change.

Seth brings two decades of healthcare integration experience to Clearway Health

Seth most recently served as senior vice president of integration at Millennium Physician Group, one of the largest independent physician groups in the United States, where he led integration of new provider groups and strategic partnerships. He previously held senior leadership positions at Optum Health and Privia Health, focusing on multidisciplinary scalability across clinical operations, finance, technology, human resources and revenue cycle functions.

Berlin – September 13, 2026 -- Four of Germany's leading scientific and health organizations have issued a joint call for a cross-departmental national prevention strategy, warning that roughly 40 percent of new cancer cases remain preventable despite decades of research.

Four organizations unite behind a joint policy statement

The Leopoldina National Academy of Sciences, the German Council of Science and Humanities (Wissenschaftsrat), the German Cancer Research Center (DKFZ) and German Cancer Aid (Deutsche Krebshilfe) presented a shared statement demanding that prevention be embedded across all policy fields -- including education, labor, transport, urban planning, environment and social affairs -- rather than confined to the health ministry alone.

Dublin – – September 13, 2026 -- LUMA Vision has secured an expanded FDA clearance for VERAFEYE, its procedural intelligence platform for minimally invasive cardiac procedures, moving the company closer to a planned commercial launch in early 2027.

VERAFEYE now unifies digital anatomy creation, catheter tracking, and guidance on a single platform

The new clearance allows VERAFEYE to reconstruct 3D models of the left and right atria with CT-like accuracy using a single 360° imaging catheter that captures raw ultrasound data. The platform lets physicians visualize and document ablation delivery directly on the anatomy while maintaining continuous tracking of both imaging and ablation catheters through electromagnetic tracking and automated imaging.

Tucson – September 13, 2026 -- Delta Development Team (DDT) has launched BloodCOMM®, a cloud-based blood management platform designed to digitize and automate blood supply chain tracking for hospitals, blood centers, EMS agencies, and air medical providers.

Platform creates digital identity for every blood unit from collection to disposition

BloodCOMM® uses barcode scanning, AI-powered label recognition, and automated event tracking to monitor blood unit location, temperature, expiration status, inspections, transfers, and excursions throughout the product lifecycle. The system builds a digital cold chain of custody record, capturing patient identifiers, product details, and deviation history as events occur rather than reconstructing them from paper logs or spreadsheets after the fact.

Jacksonville, Fla. – September 13, 2026 -- Alan Alwakeel, a recent graduate of Stanton College Preparatory School, received a $3,000 Humane Science Award from the National Anti-Vivisection Society (NAVS) for an AI-powered cancer therapy simulation platform that eliminates the need for animal testing.

Platform simulates cancer treatment efficacy without animal trials

Alwakeel's project, "The Virtual Cell 2.0: Expanding Precision and Personalized Cancer Therapy Through AI-Powered Simulation," applies computational frameworks to evaluate potential cancer treatment outcomes. The tool aims to accelerate how new therapies are developed, tested and deployed by replacing traditional animal-based testing methods with data-driven simulation.

San Francisco – September 13, 2026 -- Cionic reported that the first 60 participants in its TRANSFORM study showed an average 26% improvement in health-related quality of life after one month, using the standardized EQ-5D-5L instrument across all five measured dimensions.

Cionic launches 12-month study tracking 1,000 adults with upper motor neuron conditions

The TRANSFORM study follows 1,000 adults with multiple sclerosis, stroke, spinal cord injury, cerebral palsy, and related conditions over 12 months, collecting quality-of-life data through six surveys administered via the Cionic mobile app at onboarding and at one, three, six, nine, and 12 months. The primary endpoint, EQ-5D-5L, measures mobility, self-care, usual activities, pain, and anxiety/depression, while secondary measures track spasticity, urinary incontinence, and fatigue.

Berlin – – September 12, 2026 -- The German Medical Association (Bundesärztekammer, BÄK) has called for suicide prevention to be treated as a core duty for physicians across all medical specialties, not just psychiatry, ahead of World Suicide Prevention Day on September 10, 2026.